Adeoye Y Olukotun
CIK 1242615 · Chief Medical Officer · last filed 2026-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARWR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
695 KMS PL
ANN ARBOR, MI 48108
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Director | 31,600 | $58.16 | $1.84M | -$1.88M | 13 | 2026-08-20 |
| TNXP | Director | 0 | $4.74 | $0 | $5.0K | 11 | 2026-05-14 |
| BIOCLINICA INC (BIOC) Delisted | Director | 0 | $0.43 | $0 | $0 | 3 | 2013-03-14 |
| ICAGEN INC (ICGN) Delisted | Director | 0 | — | — | $0 | 11 | 2011-10-28 |
| BIOCLINICA INC (UWBK) Delisted | Director | — | — | — | $0 | 3 | 2010-05-13 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Chief Medical Officer | 59,624 | — | — | $0 | 3 | 2007-12-19 |
Recent Filings · Page 4 of 5
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-03-14 | BIOCLINICA INC (BIOC) Delisted | U | −52,000 | -$377.0K | EDGAR |
| 2012-05-17 | BIOCLINICA INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-10-28 | ICAGEN INC (ICGN) Delisted | Disp (D) | −7,062 | -$42.4K | EDGAR |
| 2011-09-07 | ICAGEN INC (ICGN) Delisted | U | −11,141 | -$66.8K | EDGAR |
| 2011-09-06 | ICAGEN INC (ICGN) Delisted | Exer (M) | +4,500 | $14.4K | EDGAR |
| 2011-06-06 | ICAGEN INC (ICGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-13 | BIOCLINICA INC (BIOC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-05 | ICAGEN INC (ICGN) Delisted | Grant (A) | +7,062 | $0 | EDGAR |
| 2010-06-08 | ICAGEN INC (ICGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-13 | BIOCLINICA INC (UWBK) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.